Course & Conference Booklet

Download or view full Course & Conference Booklets below

Image by Rich Tervet
 

Workshop Day 1: Lecture

24 Aug 2022

  • Part 1 – The Peritoneum

  • Part 2 – Peri and Intra-operative Considerations

  • Part 3 – Colorectal Cancer

  • Part 4 – Gastric Cancer

  • Lunch Symposium (Sponsored by Sanofi)

  • Part 5 – Pseudomxyoma Peritonei

  • Part 6 – Mesothelioma

  • Part 7 - Ovarian Cancer

  • Part 8 – Technical aspects

 

Workshop Day 2: Hands On

25 Aug 2022

  • PIPAC model

  • Central abdomen (omentum, small bowel) and flanks

  • Pelvis (bladder, THBSO, peritoneum)

  • Right upper abdomen (Liver capsule, Morison’s pouch, hepatoduodenal ligament)

  • Left upper abdomen (splenectomy, pancreas, stomach)

  • Central upper abdomen (portal triad, lesser sac, caudate lobe)

  • Set up of HIPEC

 

Conference Day 1:

26 Aug 2022

0815– 0830

Opening Speech by Clin. Assoc. Prof. Claramae Chia (Senior Consultant and Head of Department of Sarcoma, Peritoneal and Rare Tumours)


0830 – 0845

Welcome Speech by Prof. Ivy Ng (Group Chief Executive Officer, SingHealth)


Plenary lecture

0845– 0915

Priorities and Strategies in Setting Up a Comprehensive Peritoneal Centre

Speaker: Prof. Dr. med. Beate Rau


0915 – 0945

Thinking outside the box: What HIPEC can and cannot be expected to do

Speaker: Prof. Paul Sugarbaker


0945 – 1015

Latest innovations and inventions to facilitate care in patients with peritoneal metastases

Speaker: Prof. Dr. med. Marc Raymond


1015 - 1030

Q&A


1030 – 1100

Tea Break


Gynae Session

1100 - 1130

Surgical Strategies for Stage 4 Ovarian Cancer

Speaker: Prof. Dennis Chi


1130- 1200

Harnessing Biomarkers and Molecular Genetics for Therapy in Ovarian Cancers

Speaker: Assoc. Prof. David Tan


1200 - 1230

Role of Surgery for Ovarian Cancer in the New Era of Targeted and Immunotherapy

Speaker: Prof. Willemien van Driel


1230 -1245

Q&A


1245- 1330

Lunch


1330 -1430

Lunch Symposium

(Sponsored by AstraZeneca)

Integrating PARPi Therapy into the Treatment of Ovarian Cancer               

Chairperson: Dr Jack Chan

Speaker: Dr Robert Coleman


Breakout Rooms


1430 - 1500


Room 1

Pressurized Intraperitoneal Aerosolized Chemotherapy: How I do it Demonstrator and Speaker: Prof. Jimmy So


Room 2

Pearls of Cytoreductive Surgery and HIPEC

Demonstrator and Speaker: Clin. Assoc. Prof. Claramae Chia


Room 3

Poster Presentation of selected abstracts


1500-1530

Tea Break


Science Session

1530 – 1630

Implications of the genomic landscape of peritoneal metastases on diagnosis, therapy and way forward

Speaker: Prof. Jaffer Ajani


1630 – 1700

Biological hallmarks of peritoneal carcinomatosis

Speaker: Asst. Prof. Raghav Sundar

1700 – 1730

Getting the drug to the disease- Challenges and Future potential applications

Speaker: Prof. Dr. Wim Ceelen

1730 – 1800 A prospective study evaluating the role of ligand inhibition of paracrine factors in ascites

Speaker: Asst. Prof. Johnny Ong

1800 - 1815 

Q&A

 

Conference Day 2:

27 Aug 2022

Gastric and Colorectal Session

0830 - 0900

Targeted Therapy, biologics and immunotherapy for gastrointestinal peritoneal metastases

Speaker: Prof. Dr. med. Florian Lordick

0900 -0930

Surgical Advances and algorithms in the treatment of gastric peritoneal metastases

Speaker: Dr. Vahan Kepenekian

0930 -1000

Latest evidence in the treatment of gastric peritoneal metastases

Speaker: Prof. Hironori Ishigami

1000 – 1030

Making sense of Evidence Based Medicine for Colorectal Peritoneal Carcinomatosis

Speaker: Dr. Delia Cortes Guiral

1030-1045

Q&A

1045 -1115

Tea Break

Palliative Care Session

1115 -1145

Parenteral and Enteral Nutrition for Patients with Peritoneal Carcinomatosis: Choices and Pitfalls

Speaker: Clin. Asst. Prof. Ennaliza Salazar

1145– 1215

Comprehensive Palliative Care for Peritoneal Carcinomatosis

Speaker: Clin. Asst. Prof. Zhou Xuelian Jamie

1215 – 1245

Psychosocial Considerations in Complex Oncology Patients

Speaker: Dr. Irene Teo Eng Ai

1245-1300

Q&A

1300 – 1345

Lunch

Lunch Symposium

​(Sponsored by Bristol-Myers Squibb)

1345 – 1350

Welcome and Introduction

1350 - 1400

Surgical perspectives on management of resectable oesophageal cancer

Speaker: Dr Grace Tan

1400 - 1435

Immunotherapy: The new frontier for resectable oesophageal cancer

Dr Ken Kato

1435-1445

Q&A discussion

PMP and Mesothelioma Session

1445 – 1515

Rare indications for CRS and HIPEC for peritoneal metasteses

Speaker: Dr. Vahan Kepenekian

1515 – 1545

Management of mesotheliomas: Prognostication and successful therapies

Speaker: Prof. Marcello Deraco

1545 - 1600 

Q&A